Psychopharmacology for Mental Health Professionals is organized by PESI HealthCare and will be held on Feb 13, 2018 at Embassy Suites by Hilton Charlotte Ayrsley, Charlotte, North Carolina, United States of America.
The target audience for this medical event is Counselors, Psychotherapists, Psychologists, Social Workers, Nurse Practitioners Case Managers, Marriage & Family Therapists, Addiction Counselors, Nurses, Clinical Nurse Specialists, Pharmacists, School Psychologists, Other Mental Health Professionals. This CME Conference has been approved for a maximum of 6.3 contact hours.
Conference Description :
Most clients with DSM-5 diagnoses are being treated with a combination of psychological and pharmacological treatments. Newer drugs are being developed to treat mental disorders based on a better understanding of neurobiological contributions to mental disorders and the latest pharmacological research. To provide appropriate services, you are expected to have a thorough understanding of these common and complex issues. As a mental health professional, keeping up-to-date is essential.
This seminar will update and increase your knowledge of :
• Neurobiological underpinnings of major DSM-5 diagnoses
• Effects and side effects of drugs used to treat these diagnoses
• Responsibilities of the non-prescribing therapist to clients taking psychiatric medication
Specifics of the pharmacological treatment and drugs of choice for Depressive, Bipolar, Schizophrenia Spectrum, Anxiety, OCD, Sleep-Wake, ADHD and Neurocognitive disorders will be presented. Unique to this seminar is information on the common types of psychotherapeutic drugs and other drugs that are abused, and methods for prevention and early detection. Throughout the day, representative case studies will generate discussion and examination of the latest drug treatment for DSM-5® disorders. You will leave this seminar with knowledge and confidence regarding effective and safe application of pharmacological drugs.
Conference Objectives are :
• Communicate the neurotransmitter systems and neuroanatomy underlying the biological basis for mental disorders and pharmacotherapy.
• Evaluate the role of mental health professionals with clients receiving both psychotherapeutic medications and psychotherapy.
• Analyze the major classes of drugs used to treat mental disorders and which mental disorders are appropriately treated with each class of drugs.
• Compare and contrast the effects/side effects of antipsychotics, antidepressants, benzodiazepines and other antianxiety agents, anticonvulsants and drugs used to treat other mental disorders including OCD, ADHD, and cognitive impairment.
• Determine the abuse liability of drugs used in the treatment of anxiety, insomnia, pain and ADHD.
• Implement methods for prevention and early identification of prescription drug abuse.
|Contact No.||:||(800) 844-8260|
|Registration Type||End Date||Price|
|Single Registration : Early Fee||24 Jan,2018||USD 199.99|
|Single Registration Fee||12 Feb,2018||USD 219.99|
|2+ Group Rate : per person||12 Feb,2018||USD 199.99|